THE ACADEMY FOR CANCER WELLNESS

November, 2001

Volume 2, Issue 1

The Academy for Cancer Wellness would like to announce that we have been granted permanent 501(C)3 status, for 100% charitable organizations.  This means that all donations to The Academy are tax-deductible.  We greatly appreciate all donations, from services in kind, product and monetary donations, and invite you to check out our fund-raising events for the coming months.  Click here for Details!

ACW welcomes:

• Robert Rider,
  

• Della Clark,
  

• Ethel W Rittenhouse-Voss,

  Fitness trainer and educator

We are looking for volunteers to help with future awareness and fund-raising efforts.  Please contact The Academy for Cancer Wellness for more information.

Studies have shown that the breast cancer drug tamoxifen also has a positive impact on cholesterol levels. But at least in the short term, the drug does not appear to protect against heart disease, according to results from the Breast Cancer Prevention Trial (BCPT).
  Writing in the Journal of the National Cancer Institute, Dr. Steven Reis of the University of Pittsburgh Medical Center and colleagues reported results from the BCPT showing that tamoxifen 

taken by women at high risk of breast cancer reduced the chance of developing breast cancer by about half.
  However, in addition to looking at tamoxifen's effect on breast disease, the researchers conducting the BCPT trial followed the 13,388 participants to see whether the drug had any affect on heart health. After an average follow-up of 49 months, they found no significant difference in the rate of

(Continued on page 4)